VIZZIA Technologies Deploys CenTrak's Clinical-Grade Real-Time Location System™ (RTLS) to transform the patient experience at Florida Cancer Specialists

 

The largest privately-held independent oncology/hematology practice in the United States selects VIZZIA's advanced workflow optimization solution to streamline clinical processes and enhance their outpatient experience.

/PRNewswire/ -- VIZZIA Technologies, a leading provider of process and technology solutions, announced today that its clinical workflow optimization solution was recently installed at Florida Cancer Specialists & Research Institute's (FCS) Tampa Cancer Center location. The newly constructed 35,990 square foot flagship facility offers a "one-stop" approach to patient care that includes medical oncology, advanced radiation oncology technology and radiological services for identifying and diagnosing tumors.  The VIZZIA solution, which leverages CenTrak's Clinical-Grade RTLS™, is designed to transform the outpatient experience and help in optimizing patient flow processes. Shortening patient wait times, ensuring patient safety and satisfaction, as well as increasing the cancer center's patient treatment capacity are among the benefits of the new solution.

"Cancer treatment can be a daunting challenge for many of our patients. We are proud to have installed the latest technologies to enhance our patients' experiences at our center. VIZZIA's advanced workflow solution allows us the visibility and data we need to accelerate the overall treatment process, so our patients can more quickly return to their normal routines," said Todd Schonherz, Florida Cancer Specialists' chief operating officer.

VIZZIA integrated its web-based information portal with the CenTrak Clinical-Grade Locating™ infrastructure. Their VIZZION Suite™ software automatically updates the location of patients and staff from CenTrak's RTLS and incorporates important workflow rules and alerts to ensure that patients move through the treatment process as efficiently as possible. The Clinical-Grade RTLS platform uses battery-operated Gen2IR™ and Virtual Wall™ devices to deliver unmatched room-, bed-, and bay-level accuracy. The advanced technology delivers rapid location update speeds and offers small, full featured tags with extremely long battery life.

About Florida Cancer Specialists & Research Institute Florida Cancer Specialists & Research Institute (FCS) is the largest independent privately-held oncology/hematology practice in the United States. With over 150 physicians, 90 nurse practitioners/physicians assistants and more than 60 clinical sites in our network, we are committed to providing world-class cancer care in community-based settings close to home. Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. Our physicians are consistently ranked nationally as Top Doctors by U.S. News & World ReportTrained at prestigious medical schools and research institutes such as Duke, Stanford, Harvard, Emory, M.D. Anderson, Moffitt and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in the state's leading hospitals. Established in 1984, FCS serves patients on the Gulf Coast from Naples to the greater Tampa Bay area, north as far as Tallahassee, in Orlando and surrounding Central Florida communities, and on the east coast in Palm Beach County. In 2012, FCS was recognized by Modern Healthcare as one of the 40 fastest growing healthcare companies in the United States. At Florida Cancer Specialists, our primary purpose – and our passion – is to provide the most advanced cancer treatment, using cutting-edge technologies, in a setting where patients can be close to home and surrounded by family and friends.

Read more Press Releases - Insurance stories from the Miami Herald

Join the
Discussion

The Miami Herald is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere on the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

The Miami Herald uses Facebook's commenting system. You need to log in with a Facebook account in order to comment. If you have questions about commenting with your Facebook account, click here.

Have a news tip? You can send it anonymously. Click here to send us your tip - or - consider joining the Public Insight Network and become a source for The Miami Herald and el Nuevo Herald.

Hide Comments

This affects comments on all stories.

Cancel OK

  • Videos

  • Quick Job Search

Enter Keyword(s) Enter City Select a State Select a Category